Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Retained Earnings (2021 - 2025)

Historic Retained Earnings for Roivant Sciences (ROIV) over the last 5 years, with Q4 2025 value amounting to -$695.0 million.

  • Roivant Sciences' Retained Earnings fell 25095.57% to -$695.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$695.0 million, marking a year-over-year decrease of 25095.57%. This contributed to the annual value of $116.1 million for FY2025, which is 7985.67% down from last year.
  • Per Roivant Sciences' latest filing, its Retained Earnings stood at -$695.0 million for Q4 2025, which was down 25095.57% from -$429.1 million recorded in Q3 2025.
  • In the past 5 years, Roivant Sciences' Retained Earnings registered a high of $727.3 million during Q4 2023, and its lowest value of -$4.4 billion during Q3 2023.
  • Its 5-year average for Retained Earnings is -$1.6 billion, with a median of -$2.0 billion in 2021.
  • As far as peak fluctuations go, Roivant Sciences' Retained Earnings soared by 11945.1% in 2023, and later tumbled by 25095.57% in 2025.
  • Over the past 5 years, Roivant Sciences' Retained Earnings (Quarter) stood at -$2.5 billion in 2021, then tumbled by 49.57% to -$3.7 billion in 2022, then soared by 119.45% to $727.3 million in 2023, then tumbled by 36.7% to $460.4 million in 2024, then crashed by 250.96% to -$695.0 million in 2025.
  • Its Retained Earnings stands at -$695.0 million for Q4 2025, versus -$429.1 million for Q3 2025 and -$315.6 million for Q2 2025.